David Jin
Vermogen: 36 771 $ op 31-05-2026
Vermogen: 36 771 $ op 31-05-2026
David K.
Jin is currently President, CEO, Director & Chief Medical Officer at GenExosome Technologies, Inc. since 2017.
Dr. Jin is also Chief Executive Officer & Director at Avalon Heathcare Systems, Inc. Formerly, Dr. Jin was President, Chief Executive Officer & Director at Avalon GloboCare Corp.
from 2016 to 2025.
Dr. Jin served as Chief Medical Officer at AdvisoryCloud, Inc. Dr. Jin was Chief Medical Officer at Lineage Cell Therapeutics, Inc. from 2009 to 2016.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2026 | 103.000 ( 0,85% ) | 36 771 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Algemeen Directeur | 27-09-2017 |
Avalon Heathcare Systems, Inc. | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| AVALON GLOBOCARE CORP. | Algemeen Directeur | 30-11-2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Avalon GloboCare Corp.
Avalon GloboCare Corp. BiotechnologyHealth Technology Provides biotechnology and healthcare service | Health Technology |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Commercial Services |
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Miscellaneous |
Avalon Heathcare Systems, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau